← Back to Episodes
PODCAST

Fibroids, Fatty Liver, and Bones — Your Body Has Notes

August 13, 2026·9:37·Episode 101

Quick Summary

This episode covers three studies published in August 2026 touching on fibroid care in the perimenopausal transition, fatty liver disease risk accumulation in postmenopausal women, and what standard DXA bone scans may not be capturing about bone metabolism. Nykki examines what the research actually says, where the gaps are, and why these conditions intersect with menopause more than most clinicians discuss.

Fibroids, Fatty Liver, and Bones — Your Body Has Notes

0:000:00

Key Takeaways

  • Uterine fibroids (leiomyomas) affect up to 70-80% of women by age 50, but treatment decisions are still largely one-size-fits-all rather than tailored to symptom phenotype, reproductive stage, or long-term goals.
  • A 2026 study found that in postmenopausal women, it's not just body fat but the accumulation of multiple cardiometabolic risk factors together — insulin resistance, dyslipidemia, hypertension — that predicts more severe hepatic steatosis (fatty liver).
  • Standard DXA scans measure bone density but don't capture bone turnover rate — how fast bone is being broken down and rebuilt — which matters especially during and after menopause when that rate accelerates.
  • Bone turnover markers (blood and urine tests) can give a more dynamic picture of skeletal health than a single DXA reading, and research suggests they may be underused in routine postmenopausal care.
  • Women with multiple cardiometabolic risk factors after menopause may warrant liver screening conversations with their doctors, even in the absence of symptoms.

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.